Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 387

1.

First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia.

Odibo AO, Rada CC, Cahill AG, Goetzinger KR, Tuuli MG, Odibo L, Macones GA, England SK.

J Perinatol. 2013 Sep;33(9):670-4. doi: 10.1038/jp.2013.33.

PMID:
23558430
2.

Maternal plasma soluble fms-like tyrosine kinase-1 and free vascular endothelial growth factor at 11 to 13 weeks of gestation in preeclampsia.

Akolekar R, de Cruz J, Foidart JM, Munaut C, Nicolaides KH.

Prenat Diagn. 2010 Mar;30(3):191-7. doi: 10.1002/pd.2433.

PMID:
20101671
3.

Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.

Kienast C, Moya W, Rodriguez O, Jijón A, Geipel A.

J Matern Fetal Neonatal Med. 2016;29(4):537-43. doi: 10.3109/14767058.2015.1012063.

PMID:
25708492
4.

Uterine artery Doppler and sFlt-1/PlGF ratio: prognostic value in early-onset pre-eclampsia.

Gómez-Arriaga PI, Herraiz I, López-Jiménez EA, Escribano D, Denk B, Galindo A.

Ultrasound Obstet Gynecol. 2014 May;43(5):525-32. doi: 10.1002/uog.13224.

5.

Added value of angiogenic factors for the prediction of early and late preeclampsia in the first trimester of pregnancy.

Crovetto F, Figueras F, Triunfo S, Crispi F, Rodriguez-Sureda V, Peguero A, Dominguez C, Gratacos E.

Fetal Diagn Ther. 2014;35(4):258-66. doi: 10.1159/000358302.

PMID:
24714555
6.

A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia.

Kusanovic JP, Romero R, Chaiworapongsa T, Erez O, Mittal P, Vaisbuch E, Mazaki-Tovi S, Gotsch F, Edwin SS, Gomez R, Yeo L, Conde-Agudelo A, Hassan SS.

J Matern Fetal Neonatal Med. 2009 Nov;22(11):1021-38. doi: 10.3109/14767050902994754.

7.

Placental growth factor and soluble fms-like tyrosine kinase-1 are useful markers for the prediction of preeclampsia but not for small for gestational age neonates: a longitudinal study.

Rizos D, Eleftheriades M, Karampas G, Rizou M, Haliassos A, Hassiakos D, Vitoratos N.

Eur J Obstet Gynecol Reprod Biol. 2013 Dec;171(2):225-30. doi: 10.1016/j.ejogrb.2013.08.040.

PMID:
24035323
8.

Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.

Noori M, Donald AE, Angelakopoulou A, Hingorani AD, Williams DJ.

Circulation. 2010 Aug 3;122(5):478-87. doi: 10.1161/CIRCULATIONAHA.109.895458. Erratum in: Circulation. 2011 Sep 13;124(11):e302.

9.

Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.

Leaños-Miranda A, Campos-Galicia I, Isordia-Salas I, Rivera-Leaños R, Romero-Arauz JF, Ayala-Méndez JA, Ulloa-Aguirre A.

J Hypertens. 2012 Nov;30(11):2173-81. doi: 10.1097/HJH.0b013e328357c0c9.

PMID:
22902831
10.

Serum placental growth factor and fms-like tyrosine kinase 1 during first trimester in Chinese women with pre-eclampsia--a case-control study.

Wa Law L, Sahota DS, Chan LW, Chen M, Lau TK, Leung TY.

J Matern Fetal Neonatal Med. 2011 Jun;24(6):808-11. doi: 10.3109/14767058.2010.531309.

PMID:
21534854
11.

Inhibin A, activin A, placental growth factor and uterine artery Doppler pulsatility index in the prediction of pre-eclampsia.

Yu J, Shixia CZ, Wu Y, Duan T.

Ultrasound Obstet Gynecol. 2011 May;37(5):528-33. doi: 10.1002/uog.8800.

12.

Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction.

Crispi F, Llurba E, Domínguez C, Martín-Gallán P, Cabero L, Gratacós E.

Ultrasound Obstet Gynecol. 2008 Mar;31(3):303-9.

13.

First trimester screening for early and late preeclampsia based on maternal characteristics, biophysical parameters, and angiogenic factors.

Crovetto F, Figueras F, Triunfo S, Crispi F, Rodriguez-Sureda V, Dominguez C, Llurba E, Gratacós E.

Prenat Diagn. 2015 Feb;35(2):183-91. doi: 10.1002/pd.4519.

PMID:
25346181
14.

The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia.

Chaiworapongsa T, Romero R, Whitten AE, Korzeniewski SJ, Chaemsaithong P, Hernandez-Andrade E, Yeo L, Hassan SS.

J Matern Fetal Neonatal Med. 2016;29(8):1214-28.

PMID:
26303962
15.

The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.

Erez O, Romero R, Espinoza J, Fu W, Todem D, Kusanovic JP, Gotsch F, Edwin S, Nien JK, Chaiworapongsa T, Mittal P, Mazaki-Tovi S, Than NG, Gomez R, Hassan SS.

J Matern Fetal Neonatal Med. 2008 May;21(5):279-87. doi: 10.1080/14767050802034545.

16.

Smoking during pregnancy: changes in mid-gestation angiogenic factors in women at risk of developing preeclampsia according to uterine artery Doppler findings.

Llurba E, Sánchez O, Domínguez C, Soro G, Goya M, Alijotas-Reig J, Cabero L.

Hypertens Pregnancy. 2013;32(1):50-9. doi: 10.3109/10641955.2012.704107.

PMID:
22988942
17.

Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy.

Park HJ, Kim SH, Jung YW, Shim SS, Kim JY, Cho YK, Farina A, Zanello M, Lee KJ, Cha DH.

BMC Pregnancy Childbirth. 2014 Jan 20;14:35. doi: 10.1186/1471-2393-14-35.

18.

Prediction of pre-eclampsia during early pregnancy in primiparas with soluble fms-like tyrosine kinase-1 and placental growth factor.

Rohra DK, Zeb A, Qureishi RN, Azam SI, Khan NB, Zuberi HS, Sikandar R.

Natl Med J India. 2012 Mar-Apr;25(2):68-73.

PMID:
22686711
19.

Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks.

Bakalis S, Peeva G, Gonzalez R, Poon LC, Nicolaides KH.

Ultrasound Obstet Gynecol. 2015 Oct;46(4):446-51. doi: 10.1002/uog.14863.

20.

Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort.

Villa PM, Hämäläinen E, Mäki A, Räikkönen K, Pesonen AK, Taipale P, Kajantie E, Laivuori H.

BMC Pregnancy Childbirth. 2013 May 12;13:110. doi: 10.1186/1471-2393-13-110.

Supplemental Content

Support Center